Gitte M Knudsen Selected Research

Dextroamphetamine (Dexedrine)

1/2020

Serotonin release measured in the human brain: a PET study with [11C]CIMBI-36 and d-amphetamine challenge.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gitte M Knudsen Research Topics

Disease

19	Schizophrenia (Dementia Praecox) 01/2024 - 02/2007
13	Mood Disorders (Mood Disorder) 01/2024 - 02/2008
13	Major Depressive Disorder (Major Depressive Disorders) 12/2023 - 06/2014
11	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 02/2006
8	Cognitive Dysfunction 01/2024 - 02/2005
7	Mental Disorders (Mental Disorder) 01/2024 - 01/2003
5	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2024 - 02/2008
5	Psychotic Disorders (Schizoaffective Disorder) 01/2024 - 05/2013
5	Parkinson Disease (Parkinson's Disease) 01/2020 - 02/2011
4	Epilepsy (Aura) 10/2023 - 01/2018
4	Brain Diseases (Brain Disorder) 11/2022 - 01/2013
4	Seasonal Affective Disorder 10/2018 - 06/2010
4	Pain (Aches) 01/2018 - 02/2009
4	Parkinsonian Disorders (Parkinsonism) 07/2013 - 02/2011
3	Migraine Disorders (Migraine) 01/2019 - 01/2018
3	Obesity 08/2014 - 10/2012
3	Hemorrhage 01/2008 - 02/2005
2	Alcoholism (Alcohol Abuse) 01/2021 - 08/2012
2	Feeding and Eating Disorders (Eating Disorder) 08/2015 - 02/2008
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 08/2015 - 09/2005
2	Listeriosis (Listeria Infection) 04/2015 - 12/2013
2	Infections 12/2013 - 11/2010
2	Dementia (Dementias) 07/2013 - 01/2013
2	Overweight 01/2013 - 10/2012
2	Hyperphagia (Overeating) 01/2013 - 10/2012
2	Bipolar Disorder (Manic Depressive Psychosis) 10/2010 - 10/2009
1	Cluster Headache (Cluster Headaches) 01/2024
1	Hypersensitivity (Allergy) 12/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 07/2022
1	Sleep Deprivation 01/2022
1	Parkinson Disease 16 01/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020
1	Substance-Related Disorders (Drug Abuse) 01/2020
1	Stroke (Strokes) 01/2018
1	Ischemic Stroke 01/2018
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2017
1	Glioblastoma (Glioblastoma Multiforme) 09/2015
1	Sleep Wake Disorders 08/2015
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 08/2015
1	Foodborne Diseases 04/2015
1	Weight Gain 11/2014

Drug/Important Bio-Agent (IBA)

23	Serotonin (5 Hydroxytryptamine)IBA 11/2023 - 11/2007
20	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 04/2024 - 02/2005
8	Antipsychotic Agents (Antipsychotics)IBA 01/2020 - 02/2007
8	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 12/2017 - 06/2009
6	Biomarkers (Surrogate Marker)IBA 04/2024 - 03/2008
6	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021 - 08/2012
6	altanserinIBA 03/2012 - 02/2005
5	Antidepressive Agents (Antidepressants)IBA 01/2023 - 10/2010
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2010
5	Serotonin ReceptorsIBA 01/2020 - 01/2003
4	5-HT4 Serotonin ReceptorsIBA 01/2023 - 01/2018
3	Hallucinogens (Psychedelics)IBA 11/2022 - 01/2019
3	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 03/2020 - 09/2011
3	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 07/2013 - 01/2013
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2012 - 05/2008
2	Psilocybin (Psilocibin)IBA 01/2024 - 01/2019
2	Escitalopram FDA Link 12/2023 - 10/2023
2	Messenger RNA (mRNA)IBA 01/2022 - 05/2013
2	LigandsIBA 01/2021 - 02/2011
2	pimavanserinIBA 01/2020 - 03/2015
2	SB 207145IBA 01/2019 - 01/2018
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 08/2015 - 06/2009
2	Quetiapine Fumarate (Seroquel)FDA Link 11/2014 - 02/2011
2	Dopamine (Intropin)FDA LinkGeneric 01/2013 - 02/2011
2	3- amino- 4- (2- dimethylaminomethylphenylsulfanyl)benzonitrileIBA 03/2012 - 01/2011
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2008 - 01/2007
1	alpha7 Nicotinic Acetylcholine ReceptorIBA 01/2024
1	17-hydroxyestrane-3-carbonitrile (ECN)IBA 12/2023
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	Hormones (Hormone)IBA 01/2023
1	Biogenic Amines (Biogenic Amine)IBA 12/2022
1	Protein Isoforms (Isoforms)IBA 09/2022
1	gamma-Aminobutyric Acid (GABA)IBA 01/2021
1	(methyl- (11)C)N- acetyl- N- (2- methoxybenzyl)- 2- phenoxy- 5- pyridinamineIBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2020
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 01/2020
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2020
1	5-HT1B Serotonin ReceptorIBA 01/2018
1	5- methyl- 8- (4- methyl- piperazin- 1- yl)- 4- oxo- 4H- chromene- 2- carboxylic acid (4-morpholin-4-yl-phenyl)amideIBA 01/2018
1	CarbohydratesIBA 01/2017
1	SteroidsIBA 03/2016
1	Ligand-Gated Ion ChannelsIBA 09/2015
1	GadoliniumIBA 09/2015
1	Amino Acids FDA Link 09/2015
1	acetamideIBA 09/2015
1	pyridineIBA 09/2015
1	6- chloro- 2- (4'- iodophenyl)- 3- (N,N- diethyl)imidazo(1,2- a)pyridine- 3- acetamideIBA 09/2015
1	Bacteriocins (Lantibiotics)IBA 04/2015
1	DiprenorphineIBA 11/2014
1	Opioid Analgesics (Opioids)IBA 11/2014
1	VortioxetineIBA 06/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2013

Therapy/Procedure

2	Precision Medicine 10/2023 - 01/2020
2	Therapeutics 09/2022 - 01/2018
2	Lasers (Laser) 01/2008 - 02/2005
1	Cognitive Training 01/2024
1	Resuscitation 07/2022
1	Thrombectomy 01/2018